On univariate analysis of the high-grade cohort, chemotherapy predicted for a significant DC benefit (HR 0.55 95% CI 0.31–0.98, p = 0.043), but the impact on PFS (HR 0.66 95% CI 0.43–1.03, p = 0.066) and OS (HR 0.68 95% CI 0.38–1.19, p = 0.178) did not reach statistical significance.
← all excerpts
Chemotherapy improves distant control in localized high-grade soft tissue sarcoma of the extremity/trunk.
1
—
—